- Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms. Clinical Pharmacology and Therapeutics 2023.
- Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial – a qualitative study. Frontiers in Psychology vol 14, 2023
- Risk of recurrent cardiovascular events in coronary artery disease patients with Type D personality. Frontiers in Psychology, vol 14, 2023
- Psychiatric disorders, rumination, and metacognitions in patients with type D personality and coronary heart disease, Nordic Journal of Psychiatry 2023
- Achieving the unachievable: How to optimize lipid lowering therapy in survivors of acute myocardial infarction. Polish Heart Journal 2023.
- Individualisert risikoreduksjon. 2021 Guidelines in CVD prevention. Hjerteforum 2023 (#Referater, s. 90-93)
- Plasma concentration of atorvastatin metabolites correlates with low-densitylipoprotein cholesterol reduction in patients with coronary heart disease. Pharmacology Research & Perspectives 2023
- Insomnia was associated with increased risk of recurrent cardiovascular events in coronary heart disease patients. ESC Preventive Cardiology Congress, Malaga 13-15 Mai 2023. Vitenskapelig foredrag av Lars Aastebøl Frøjd, John Munkhaugen mfl.
- Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. ESC Preventive Cardiology Congress, Malaga 13-15 Mai 2023. Vitenskapelig foredrag av John Munkaugen
- Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease. ESC Preventive Cardiology Congress, Malaga 13-15 Mai 2023. Vitenskapelig foredrag av Trine Lauritzen, John Munkhaugen mfl.
- Predictors of health-related quality of life in outpatients with coronary heart disease. Frontiers in Psychlogy 2023
- Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function. Journal of Clinical Medicine 2023
- PCSK9-hemmere på blå resept for hvem? Tidsskriftet for Den norske legeforening 2023
- Validation of a novel direct method to determine reduced adherence to atorvastatin therapy. European Journal of Preventive Cardiology 2023
- Health-related quality of life in outpatients with coronary heart disease: impact of type D personality, depression, anxiety and insomnia. European Journal of Preventive Cardiology 2023
- Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease. European Journal of Preventive Cardiology 2023
- Betablokkere etter hjerteinfarkt – Skal den fortsatt gis? Hjerteposten : fagtidsskrift for NSFs landsgruppe av kardiologiske sykepleiere 2023, utgave 2, sider: 28-32.
- E. Sverre og medarbeidere svarer. Kommentar. Tidsskriftet for Den norske legeforening 2023
- Treatment patterns and adherence to lipid-lowering drugs during 8 years of follow-up after a cardiovascular event. ESC European Society of Cardiology Congress, Amsterdam 25.08-28.08. 2023. Poster presentasjon av Ingrid Engebretsen mfl.
- Treatment patterns and adherence to lipid-lowering drugs during 8 years of follow-up after a cardiovascular event. European Heart Journal 2023
- Attention training technique delivered in groups as treatment for anxiety and depression in patients with coronary heart disease: Study protocol for a waiting-list randomised controlled trial. Frontiers in Psychology 2023.
- Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease. Journal of Clinical Endocrinology and Metabolism 2023
- Atorvastatin lactonization is associated with statin-dependent muscular side effects in patient with coronary heart disease. 21st International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Oslo 24-27 September 2023. Poster presentasjon av Trine Lauritzen mfl.
- Emerging tools in statin treatment for improved cardiovascular disease prevention. 21st International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Oslo 24-27 September 2023. Vitenskapelig foredrag av John Munkhaugen.
- ESC PREVENTIVE CARDIOLOGY 2023 – utvalgte presentasjoner innen sekundærprevensjon. Hjerteforum 36(3) 2023 s. 82-84.
- Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison’s disease – a cross-sectional study | European Journal of Endocrinology | Oxford Academic (oup.com). European Journal of Endocrinology (EJE) 2023
- Skrøpelighet, helsekompetanse og egenomsorg hos pasienter som innlegges med akutt hjertesvikt. Tidsskriftet for Den norske legeforening 2023
- Editorial: Progress in Understanding and Treating Distress, Sleep, and Personality in Heart and Lung Disease. Frontiers in Psychology 2023
- Cardiac rehabilitation participation within 6 months of discharge in 37 136 myocardial infarction survivors: a nationwide registry study. European Journal of Preventive Cardiology 2023
- Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non–ST-Segment Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology 2023
- The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics. European Heart Journal – Cardiovascular Pharmacotherapy, 2023
- Ventricular arrhythmias in arrhythmic mitral valve syndrome – a prospective continuous long-term cardiac monitoring study. EP Europace, 2022/2023
- Utvalgte høydepunkter innen forebyggende kardiologi. Hjerteforum 4-2023 (artikkel, s. 109-110)
